Bioequivalence to become compulsory for generic drugs

From this year, all generic drugs produced in Korea must prove they are equivalent to the patented medicines on which they are modeled, the Korea Food and Drug Administration said.

Generic drugs would be obliged to test for bioequivalence prior to entering the market. If any manufacturers are found not to undertake bioequivalence testing on specific generic drugs, they will be eternally expe...